Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFTR | P13569 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16781718 | 0.82 | CFTR (0.58) | CFTRSLC6A2SLC6A4SLC6A3GOPC | |
| SCHEMBL8355124 | 0.81 | CFTR (0.48) | CFTRSLC6A2SLC6A4SLC6A3GOPC | |
| SCHEMBL7707812 | 0.81 | SMN1; SMN2 (0.42) | CFTRSLC6A2SLC6A4SLC6A3GOPC | |
| SCHEMBL19318473 | 0.79 | CFTR (0.50) | CFTRSLC6A2SLC6A4SLC6A3GOPC | |
| SCHEMBL19318460 | 0.79 | CFTR (0.50) | CFTRSLC6A2SLC6A4SLC6A3GOPC | |
| SCHEMBL19318472 | 0.79 | CFTR (0.50) | CFTRSLC6A2SLC6A4SLC6A3GOPC | |
| Hydrochloric Acid SCHEMBL20138991 | 0.77 | CFTR (0.48) | CFTRSLC6A2SLC6A4SLC6A3GOPC | |
| SCHEMBL6631615 | 0.76 | CFTR (0.52) | CFTRSLC6A2SLC6A4SLC6A3GOPC | |
| SCHEMBL792191 | 0.76 | CFTR (0.52) | CFTRSLC6A2SLC6A4SLC6A3GOPC | |
| SCHEMBL242044 | 0.76 | DPP4 (0.59) | KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1095035-B1 | METHOD FOR PREPARING 4-(3-PYRIDINYL)-1H-IMIDAZOLE AND THE INTERMEDIATES USED | AVENTIS PHARMA SA (FR) | 2010-03-17 | — | — | EP | disclosed |
| US-6353108-B1 | 1-(3-PYRIDINYL)-ETHANONE O-((4-METHYLPHENYL) SULPHONYL) OXIME FORMS 3-(2H-AZIRIN-3-YL)-PYRIDINE WHICH IS REACTED WITH ACID AND ALCOHOL TO OBTAIN THE 2,2-DIMETHOXY-2-(3-PYRIDINYL) ETHYL-AMINE WHICH IS REACTED WITH AN AMIDE AND CYCLIZED; INTERMEDIATES ARE NOT ISOLATED | AVENTIS PHARMA S.A. (FR) | 2002-03-05 | — | — | US | disclosed |